Biopharmaceutical Industry Is Banking on Boston Published: Jan 06, 2010 NY Times -- Companies battling for an edge in the biopharmaceutical industry have $2.3 billion in manufacturing plants in development in the Boston area to produce genetically engineered drugs. Related links New York Times This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news